| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Dairy and Swine Research and Development Centre, Agriculture and Agri-Food Canada, Lennoxville, QC, Canada
The objective of the present study was to evaluate the therapeutic potential of bovine lactoferrin or lactoferricin in combination with penicillin G against Staphylococcus aureus. Minimal inhibitory concentrations of lactoferrin, lactoferricin, penicillin, and combinations of lactoferrin or lactoferricin with penicillin were determined for 15 S. aureus strains including several strains resistant to ß-lactam antibiotics. The fractional inhibitory concentration index indicated a synergistic effect between lactoferrin and penicillin. Combination of lactoferrin with penicillin increased the inhibitory activity of penicillin by two- to fourfold and reduced the growth rate in S. aureus strains tested, whereas the increase in the inhibitory activity of lactoferrin by penicillin was 16- to 64-fold. The addition of iron to the medium containing a combination of penicillin and lactoferrin had no effect on growth inhibition. Electron microscopy revealed that concentration below the minimal inhibitory concentrations of penicillin induced important ultrastructure alterations, which were further enhanced by the presence of lactoferrin. When S. aureuscells were grown in the presence of a combination of penicillin and lactoferrin, changes in the protein profile of the bacteria, including the disappearance of several protein bands due to the presence of lactoferrin, were observed. These data suggest that bovine lactoferrin or lactoferricin in combination with ß-lactam antibiotics can increase the antibacterial activity of these antibiotics against S. aureus resistant to antibiotics.
Key Words: Lactoferrin • ßbeta;-lactam antibiotics • Staphylococcus aureus • mastitis
Submitted on October 16, 2001
Accepted on November 26, 2001
This article has been cited by other articles:
|
|
 |
|
  P. Lacasse, K. Lauzon, M. S. Diarra, and D. Petitclerc Utilization of lactoferrin to fight antibiotic-resistant mammary gland pathogens J Anim Sci, March 1, 2008; 86(13_suppl): 66 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Petitclerc, K. Lauzon, A. Cochu, C. Ster, M. S. Diarra, and P. Lacasse Efficacy of a Lactoferrin-Penicillin Combination to Treat {beta}-Lactam-Resistant Staphylococcus aureus Mastitis J Dairy Sci, June 1, 2007; 90(6): 2778 - 2787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Hyvonen, L. Suojala, T. Orro, J. Haaranen, O. Simola, C. Rontved, and S. Pyorala Transgenic Cows That Produce Recombinant Human Lactoferrin in Milk Are Not Protected from Experimental Escherichia coli Intramammary Infection Infect. Immun., November 1, 2006; 74(11): 6206 - 6212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Barkema, Y. H. Schukken, and R. N. Zadoks Invited Review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci, June 1, 2006; 89(6): 1877 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Kerr and O. Wellnitz Mammary expression of new genes to combat mastitis J Anim Sci, March 1, 2003; 81(suppl_3): 38 - 47. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
